Investors are not expecting any definitive conclusion to tariff uncertainty by the end of next week.
Related Posts
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea, expanding use in U.S.
The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance coverage for the treatment.
China considers selling TikTok U.S. operations to Musk, Bloomberg reports
The Chinese government is considering a plan for Elon Musk to acquire TikTok’s U.S. business, Bloomberg News reported on Monday.
GM cutting jobs, idling Canadian electric van plant due to ‘market demand’
General Motors is cutting production of its all-electric delivery vans at a plant in Canada ahead of idling the facility through much of this year.